FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
MVISX
Price
$63.77
Change
+$0.68 (+1.08%)
Updated
Aug 21 closing price
Net Assets
2.13B
Interact to see
Advertisement

FSMAX vs MVISX

FSMAX vs MVISX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. MVISX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and MVISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. MVISX (2.13B). FSMAX pays higher dividends than MVISX: FSMAX (0.50) vs MVISX (0.17). FSMAX was incepted earlier than MVISX: FSMAX (15 years) vs MVISX (8 years). MVISX (1.33) is less costly to investors than FSMAX (0.04). MVISX is a more actively managed with annual turnover of: 27.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than MVISX: FSMAX (0) vs MVISX (1000000). MVISX annual gain was more profitable for investors over the last year : 32.67 vs. FSMAX (23.68). MVISX (41.89) and FSMAX (40.14) have equivalent 5 years return.
FSMAXMVISXFSMAX / MVISX
Total Expense Ratio0.041.333%
Annual Report Gross Expense Ratio0.041.333%
Fund Existence15 years8 years-
Gain YTD16.93717.70096%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B2.13B1,884%
Annual Yield % from dividends0.500.17296%
Returns for 1 year23.6832.6772%
Returns for 3 years72.74123.0559%
Returns for 5 years40.1441.8996%
Returns for 10 years134.49N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3